Toho Holdings Co., Ltd. engages in the planning and management of its group of companies, which have interests in the pharmaceutical business. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 7,609 full-time employees. The company went IPO on 2002-12-11. The firm operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. The company is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
Follow-Up Questions
Toho Holdings Co Ltd의 CEO는 누구입니까?
Mr. Hiromi Edahiro은 2015부터 회사에 합류한 Toho Holdings Co Ltd의 Chief Executive Officer입니다.
THPMF 주식의 가격 성능은 어떻습니까?
THPMF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Toho Holdings Co Ltd의 주요 사업 주제나 업종은 무엇입니까?
Toho Holdings Co Ltd은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Toho Holdings Co Ltd의 시가총액은 얼마입니까?
Toho Holdings Co Ltd의 현재 시가총액은 $0입니다
Toho Holdings Co Ltd는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 4명의 분석가가 Toho Holdings Co Ltd에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 2명의 매수, 3명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다
